Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H29N3O3 |
| Molecular Weight | 371.4733 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)[C@@H](NC(=O)C1=NN(CC2CCCCC2)C3=C1C=CC=C3)C(C)C
InChI
InChIKey=CRGGXDSTBHQLKJ-SFHVURJKSA-N
InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1
| Molecular Formula | C21H29N3O3 |
| Molecular Weight | 371.4733 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:10:33 GMT 2025
by
admin
on
Mon Mar 31 23:10:33 GMT 2025
|
| Record UNII |
OU56JJP891
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-AMB-CHMINACA
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
119026010
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY | |||
|
MA-CHMINACA
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY | AB-CHMINACA (Item No. 15434) is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA (Item No. 14039), a high affinity ligand of the CB1 receptor (Ki = 0.9 nM).1,2 AB-CHMINACA metabolite M2 is a potential derivative resulting from the replacement of a terminal amide NH2 with a hydroxyl group. MA-CHMINACA is an analog of AB-CHMINACA metabolite M2 in which the hydroxyl moiety is replaced with a methyl ester group. The physiological and toxicological properties of this compound are not known. | ||
|
AMB-CHMINACA
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY | |||
|
100000183995
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY | |||
|
MA-CHMINACA
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY | |||
|
OU56JJP891
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY | |||
|
DTXSID601344891
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY | |||
|
1971007-96-1
Created by
admin on Mon Mar 31 23:10:33 GMT 2025 , Edited by admin on Mon Mar 31 23:10:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
|
RACEMATE -> ENANTIOMER |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
